UBS’s BSD MEDICAL CORP (DEL) BSDM Stock Holding History

UBS’s Portfolio BSDM Stock Details BSDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$2K	Buy	+2,700	New	+$1.89K	﹤0.01%	10100

Other funds holding BSDM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCB

Texas Capital Bancshares Dallas, Texas $254M AUM 27.01% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

UBS's BSDM Position: Q3 2014 in Review

UBS reduced its BSD MEDICAL CORP (DEL) (BSDM) stake by 61% in Q3 2014, selling an estimated $2.19K and leaving 2,000 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #10257.

UBS first reported a position in BSDM in Q2 2013 and has held it in 6 quarters since. The position peaked at $20K in Q4 2013. 22 funds tracked by Wall St. Rank hold BSDM as of Q3 2014.

UBS held 2,000 shares of BSD MEDICAL CORP (DEL) worth $1K as of Q3 2014.
UBS sold 3,124 BSD MEDICAL CORP (DEL) shares in Q3 2014, an estimated $2.19K.
BSD MEDICAL CORP (DEL) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10257 holding.
UBS first reported a position in BSD MEDICAL CORP (DEL) in Q2 2013 and has held it in 6 quarters since.
UBS's BSD MEDICAL CORP (DEL) position peaked at $20K in Q4 2013.
22 funds tracked by Wall St. Rank held BSD MEDICAL CORP (DEL) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.